Post-market surveillance (PMS) sounds like something you do after you launch. But under EU MDR, your post-market system is part of your pre-market credibility. Notified Bodies want to see that you’ve planned how you’ll monitor safety and performance once real users touch your device. The good news: you don’t need a “big company” PMS machine. […]

Most startups treat Technical Documentation like a deliverable you create at the end. Under EU MDR, that’s how you end up rewriting everything twice: once to “get something down,” and again when you realize nothing links together. The better approach is simple: set up the structure early so every decision, test, and document naturally lands […]

Clinical evaluation is where many startups lose time (and confidence) because it feels like a black box. But you don’t need to “solve clinical” in week one. You do need to make a few early decisions so you don’t build the wrong evidence plan, choose the wrong claims, or end up rewriting your strategy late. […]

Most startups create a risk file once, right before they “need it.” Under EU MDR, that approach is a trap: risk management isn’t a document you finish. It’s a decision-making systemyou run throughout development, release, and post-market. If you’re still getting oriented, start here: EU MDR for Startups: Where Do I Start? (Practical Roadmap) And […]

Most MedTech startups delay their QMS because it sounds like bureaucracy. But under EU MDR, the QMS isn’t a “later” thing. It’s the operating system that proves you build, change, and release your device in a controlled way. The trick is not to build a big-company QMS. It’s to build a startup-sized QMS that’s audit-ready […]

Most startups treat EU MDR like a compliance project that starts “later.” The teams that move faster treat it like a product roadmap: clear milestones, owners, and “unblockers” that reduce rework. If you’re new to MDR, start with the overview here. And if you’re still shaping claims, read intended purpose first (because roadmap decisions start […]

Device classification under EU MDR is one of those topics that feels technical, but it’s actually a business decision disguised as regulation. Because your class determines: – Whether you need a Notified Body (and how early you must engage)– How heavy your clinical evidence burden will be– How much QMS and technical documentation you’ll need– […]

If EU MDR feels like a mountain, there’s a surprisingly simple place to start: your intended purpose. Not your QMS. Not your technical file. Not your Notified Body. A clear, review-ready intended purpose is the sentence that drives classification, clinical strategy, labeling, and your entire technical documentation. If you haven’t read the broader roadmap yet, […]

If you’re building a medical device startup in Europe, the EU Medical Device Regulation (EU MDR) can feel like a wall of acronyms, documents, and “we’ll deal with it later.” The fastest way to lose time (and money) is to postpone MDR until you’re “closer to market.” The fastest way to gain speed is to […]